Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 1,585 shares at $16.30 ($26K) on 2025-10-08, disclosed to the SEC on 2025-10-10.
Open-market sale of $26k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |